POLUZZI, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 9.331
EU - Europa 7.713
AS - Asia 3.893
AF - Africa 625
SA - Sud America 48
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 3
Totale 21.644
Nazione #
US - Stati Uniti d'America 9.273
IT - Italia 2.037
GB - Regno Unito 1.909
CN - Cina 1.285
SG - Singapore 1.075
DE - Germania 952
SE - Svezia 827
VN - Vietnam 824
RU - Federazione Russa 417
IN - India 401
UA - Ucraina 342
IE - Irlanda 301
FR - Francia 276
CI - Costa d'Avorio 213
TG - Togo 213
ZA - Sudafrica 132
EE - Estonia 107
FI - Finlandia 84
JO - Giordania 71
BE - Belgio 64
BG - Bulgaria 60
CH - Svizzera 55
CA - Canada 54
AT - Austria 49
NL - Olanda 46
ID - Indonesia 45
HK - Hong Kong 38
JP - Giappone 36
NG - Nigeria 32
ES - Italia 29
PT - Portogallo 29
HR - Croazia 28
PL - Polonia 25
AU - Australia 22
BR - Brasile 22
TR - Turchia 21
SC - Seychelles 18
TW - Taiwan 16
GR - Grecia 15
RO - Romania 12
IR - Iran 10
CZ - Repubblica Ceca 9
NZ - Nuova Zelanda 9
UZ - Uzbekistan 9
DK - Danimarca 8
PH - Filippine 8
SA - Arabia Saudita 8
CO - Colombia 7
IL - Israele 7
CL - Cile 6
LT - Lituania 6
PE - Perù 6
SI - Slovenia 6
TH - Thailandia 6
KR - Corea 5
LB - Libano 5
MA - Marocco 5
RS - Serbia 5
SM - San Marino 5
AR - Argentina 4
EG - Egitto 4
SY - Repubblica araba siriana 4
DZ - Algeria 3
KE - Kenya 3
MT - Malta 3
MX - Messico 3
MY - Malesia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BD - Bangladesh 2
CY - Cipro 2
LK - Sri Lanka 2
NO - Norvegia 2
PK - Pakistan 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
EU - Europa 1
HU - Ungheria 1
IQ - Iraq 1
KH - Cambogia 1
KZ - Kazakistan 1
MU - Mauritius 1
MV - Maldive 1
PA - Panama 1
UG - Uganda 1
VE - Venezuela 1
Totale 21.644
Città #
Southend 1.694
Fairfield 914
Chandler 901
Singapore 898
Ashburn 824
Santa Clara 620
Dong Ket 595
Wilmington 457
Bologna 443
Princeton 417
Woodbridge 407
Seattle 380
Houston 368
Ann Arbor 362
Cambridge 296
Dublin 293
Boardman 253
Abidjan 213
Lomé 213
Jacksonville 204
Westminster 146
Nanjing 138
Padova 127
Milan 123
Berlin 116
Redmond 114
Rome 102
Beijing 93
Saint Petersburg 84
Shenyang 80
Bremen 79
Medford 75
Helsinki 74
Jinan 74
Turin 74
Amman 71
New York 69
San Diego 66
Los Angeles 64
Brussels 60
Mülheim 57
Sofia 56
Florence 52
London 49
Falls Church 47
Hebei 47
Nanchang 46
Shanghai 42
Jakarta 41
Bern 39
Dearborn 38
Zhengzhou 38
Vienna 36
Tianjin 35
Biella 34
Changsha 33
Jiaxing 33
Guangzhou 32
Redwood City 31
Abeokuta 30
Des Moines 30
Modena 30
Olalla 30
Yubileyny 30
Frankfurt am Main 27
San Venanzo 27
Palermo 25
Toronto 25
Hangzhou 24
Bühl 22
Paris 22
Porto 21
Cesena 20
Fuzhou 20
Phoenix 20
Boydton 19
Verona 19
Haikou 18
Ningbo 18
Norwalk 18
Nuremberg 18
Tokyo 18
Messina 17
Mahé 16
Wuhan 16
Chicago 15
Hong Kong 15
Kunming 15
San Francisco 15
Shenzhen 15
Chengdu 14
Miami 14
Moscow 14
Taipei 14
Central 13
Forlì 13
Istanbul 13
Ottawa 13
Taizhou 13
Columbus 12
Totale 14.155
Nome #
Leucoencefalopatia Multifocale Progressiva: complicanza dell'immunosoppressione o reazione avversa da farmaci? 452
Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe. 443
ROCCA observational study: Early results on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino using active surveillance 417
Antibiotic use varies substantially among adults: a cross-national study from five European Countries in the ARITMO project 266
Data Mining Techniques in Pharmacovigilance: Analysis of the Publicly Accessible FDA Adverse Event Reporting System (AERS) 244
ROCCA cohort study: Nationwide results on safety of Gam-COVID-Vac vaccine (Sputnik V) in the Republic of San Marino using active surveillance 243
Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems 211
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage 204
Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy 194
Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies 192
Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems 187
Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy 182
Adverse pregnancy outcomes in women exposed to gabapentin and pregabalin: data from a population-based study 181
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage. 171
Modified-Chronic Disease Score (M-CDS): Predicting the individual risk of death using drug prescriptions 171
Farmacoutilizzazione in ospedale: analisi delle variabilità in una realtà regionale 169
A 3 year survey on the use of antibacterial agents in five Italian hospitals. 167
Antibacterial macrolides: a drug class with a complex pharmacological profile 166
Biomarkers of Kidney Injury in Very-low-birth-weight Preterm Infants: Influence of Maternal and Neonatal Factors 166
Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database. 163
Antimicrobials and the Risk of Torsades de Pointes. The Contribution from Data Mining of the US FDA Adverse Event Reporting System 160
Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement 157
Switching among Equivalents in Chronic Cardiovascular Therapies: 'Real World' Data from Italy 155
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System 152
Emilia-Romagna Study on Pregnancy and Exposure to Antiepileptic drugs (ESPEA): a population-based study on prescription patterns, pregnancy outcomes and fetal health 151
An update on the first decade of the European centralized procedure: how many innovative drugs? 150
An approach to evaluate appropriateness in the antibacterial therapy in Italian hospitals. 148
Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting 142
Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database 141
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System 141
Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study 140
Clinically important drug-drug interactions in poly-treated elderly outpatients: A campaign to improve appropriateness in general practice 139
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System 139
Cardiovascular, Ocular and Bone Adverse Reactions Associated with Thiazolidinediones: A Disproportionality Analysis of the US FDA Adverse Event Reporting System Database. 138
Association between Paraesthesia and Local Anesthetics: Data Mining of the Public Version of the FDA Adverse Event Reporting System, 138
Pattern of drug use among preterm neonates: Results from an Italian neonatal intensive care unit 137
Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents. 136
Drug-induced renal injury in neonates: challenges in clinical practice and perspectives in drug development 136
Changes in prevalence and pattern of drug use in a ten years period in Italy. 8th Congress of the European Association for Clinical Pharmacology and Therapeutics 133
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping 132
Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting System 132
Disproportionality signal of progressive multifocal leukoencephalopathy: monoclonal antibodies versus other immunosuppressants 130
Social and clinical descriptors of antipsychotic prescription 130
Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis 130
Drug-induced Kounis syndrome: A matter of pharmacovigilance 130
Risk of hospitalization from drug-drug interactions in the Elderly: real-world evidence in a large administrative database 129
Drug-Induced Renal Damage in Preterm Neonates: State of the Art and Methods for Early Detection 128
A 5 years surveillance of antibiotic use and microbiological resistance in an Italian university hospital. 127
Pro-arrhythmic potential of oral antihistamines (H1): Combining adverse event reports with drug utilization data across Europe 127
La condivisione dei trattamenti farmacologici in psichiatria e la percezione degli effetti avversi ai farmaci antipisicotici da medico, paziente e familiare 126
Triptans and serious adverse vascular events: Data mining of the FDA Adverse Event Reporting System database 124
The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project 123
'Use of antipsychotics in children and adolescents: A picture from the ARITMO population-based European cohort study' 123
Initial treatment of hypertension and adherence to therapy in general practice in Italy 121
Deprescribing as a strategy for improving safety of medicines in older people: Clinical and regulatory perspective 120
Use of phytoestrogens and effects perceived by postmenopausal women: result of a questionnaire-based survey 120
Antibiotic use in Italian hospitals 2002-2004. 119
Pattern of NSAID use in the Italian general population: a questionnaire-based survey. 119
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres 117
Association between the use of proton pump inhibitors and cardiovascular events: A note of caution 117
Paraesthesia after Local Anaesthetics: An Analysis of Reports to the FDA Adverse Event Reporting System 115
Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis 115
The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database. 115
Excipients in medicinal products used in gastroenterology as a possible cause of side effects. 114
Dapagliflozin and cardiovascular outcomes: anything else to DECLARE? 114
Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics 113
QT interval shortening in spontaneous reports submitted to the FDA: the need for consensus 113
The hERG K+ channel: target and antitarget strategies in drug development. 113
Stroke, Migraine and Triptans: From Bedside to Bench 113
Challenges in Repurposing Drugs in COVID-19 Pandemic. Debating on Potential New Refinements 113
Developing a Method To Identify Prescribing Profiles of Antihypertensive Drugs in General Practice. 110
Gastro-intestinal problems and concomitant medication in NSAID users: additional findings from a questionnaire-based survey in Italy 110
Predictors of non-adherence with oral bisphosphonates: an Italian retrospective cohort study on administrative databases 110
Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective 110
Diabetes is associated with decreased migraine risk: A nationwide cohort study 110
Apparato Gastroenterico 109
Antimicrobial-induced torsades de pointes: towards risk stratification by data mining of the FDA Adverse Event Reporting System. 109
Recurrence of pericarditis after influenza vaccination: a case report and review of the literature 109
Antibiotic Use and Microbiological Surveillance: An Ecological Study in an Italian University Hospital. 108
Pattern of triptan use and cardiovascular coprescription: a pharmacoepidemiological study in Italy 107
Profile of atypical-antipsychotics use in patients affected by dementia in the University Hospital of Ferrara. 106
Use of azithromycin and risk of ventricular arrhythmia 106
Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment 104
Use of antidepressants and the risk of Parkinson's disease in the Local Health Trust of Bologna: A historical cohort study 103
Prevalence and determinants of long-term utilization of antidepressant drugs: A retrospective cohort study 103
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy 103
Macrolides and Torsadogenic Risk: Emerging Issues from the FDA Pharmacovigilance Database 102
Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance 102
The adherence to antihypertensive treatments: an Italian survey by using prescription databases. 101
Trends in antiarrhythmic drug use after marketing authorization of dronedarone: comparison between Emilia Romagna (Italy) and Sweden. 101
Analyses of natalizumab prescriptions and discontinuations in multiple sclerosis patients of an Italian region 101
Aderenza alla terapia antidepressiva in Emilia-Romagna 101
Cardiovascular events in statin recipients: a 3-year record-linkage study on prescription and hospital discharge databases 100
Use of antihistamines and risk of ventricular tachyarrhythmia: a nested case-control study in five European countries from the ARITMO project. 100
Pharmacotherapy of type 2 diabetes in patients with chronic liver disease: focus on nonalcoholic fatty liver disease 100
Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8-year period. 99
Prescription patterns of antiepileptic drugs in young women: development of a tool to distinguish between epilepsy and psychiatric disorders 99
Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the U.S. Food and Drug Administration Adverse Event Reporting System. 99
Farmaci lassativi e purganti 97
Prescription patterns of oral bisphosphonates in Italian patients with osteoporosis 97
Totale 14.200
Categoria #
all - tutte 62.835
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 230
Totale 63.065


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.614 0 0 0 0 0 0 0 480 519 268 125 222
2020/20212.665 467 163 43 132 60 151 66 175 218 150 167 873
2021/20223.831 401 121 201 192 318 226 160 267 169 229 919 628
2022/20234.598 505 599 350 549 276 322 171 304 725 189 385 223
2023/20242.067 123 226 227 297 161 209 88 344 46 133 127 86
2024/20253.864 379 780 562 367 933 372 376 95 0 0 0 0
Totale 22.301